Sublingual-oral Immunotherapy: Phase IIb data

In a double-blind, placebo-controlled Phase llb trial in 115 ragweed pollen-sensitive subjects, medium and high doses of Greer's sublingual-oral immunotherapy reduced rhinoconjunctivitis symptoms and ...